A recent study published in The BMJ suggests there exist “extensive” financial ties between influential medical associations and pharmaceutical and device companies.
The study by Ray Moynihan et al. found out of 328 leaders, 72 percent (235) had some sort of financial ties in the industry.
“The quantum of payments raises questions about independence and integrity, adding weight to calls for policy reform,” the authors write.
To read the study, click here.